dehydroepiandrosterone has been researched along with Cognitive Decline in 3 studies
Dehydroepiandrosterone: A major C19 steroid produced by the ADRENAL CORTEX. It is also produced in small quantities in the TESTIS and the OVARY. Dehydroepiandrosterone (DHEA) can be converted to TESTOSTERONE; ANDROSTENEDIONE; ESTRADIOL; and ESTRONE. Most of DHEA is sulfated (DEHYDROEPIANDROSTERONE SULFATE) before secretion.
dehydroepiandrosterone : An androstanoid that is androst-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 17. It is a naturally occurring steroid hormone produced by the adrenal glands.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study is to elucidate how patient-reported cognitive symptoms manifest from variations in hormone levels or precursors such as dehydroepiandrosterone (DHEA) and its sulfated form [collectively termed as DHEA(S)] and to investigate their association in breast cancer survivors." | 8.12 | Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy. ( Chan, A; Lau, AJ; Parajuli, R; Tan, CJ; Toh, YL; Yap, NY, 2022) |
| "Eighty-one patients with early-stage breast cancer (stages I-III) who had no prior exposure to chemotherapy and/or radiotherapy and were scheduled to receive anthracycline-based or taxane-based chemotherapy treatment with curative intent." | 5.51 | Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy. ( Bansal, S; Chan, A; Lau, AJ; Shariq Mujtaba, J; Shwe, M; Toh, YL; Yeo, A, 2019) |
| "The purpose of this study is to elucidate how patient-reported cognitive symptoms manifest from variations in hormone levels or precursors such as dehydroepiandrosterone (DHEA) and its sulfated form [collectively termed as DHEA(S)] and to investigate their association in breast cancer survivors." | 4.12 | Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy. ( Chan, A; Lau, AJ; Parajuli, R; Tan, CJ; Toh, YL; Yap, NY, 2022) |
| "Eighty-one patients with early-stage breast cancer (stages I-III) who had no prior exposure to chemotherapy and/or radiotherapy and were scheduled to receive anthracycline-based or taxane-based chemotherapy treatment with curative intent." | 1.51 | Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy. ( Bansal, S; Chan, A; Lau, AJ; Shariq Mujtaba, J; Shwe, M; Toh, YL; Yeo, A, 2019) |
| "Younger caregivers were prone to cognitive impairments similar to older caregivers, although the degree and the neuropsychological correlates of the cognitive dysfunctions were somewhat different between the two groups." | 1.43 | Age Effects on Cognitive and Physiological Parameters in Familial Caregivers of Alzheimer's Disease Patients. ( Argimon, II; Bromberg, E; Corrêa, MS; Ferrari, P; Giacobbo, BL; Lima, DB; Vedovelli, K; Walz, JC, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Toh, YL | 2 |
| Tan, CJ | 1 |
| Yap, NY | 1 |
| Parajuli, R | 1 |
| Lau, AJ | 2 |
| Chan, A | 2 |
| Shariq Mujtaba, J | 1 |
| Bansal, S | 1 |
| Yeo, A | 1 |
| Shwe, M | 1 |
| Corrêa, MS | 1 |
| Giacobbo, BL | 1 |
| Vedovelli, K | 1 |
| Lima, DB | 1 |
| Ferrari, P | 1 |
| Argimon, II | 1 |
| Walz, JC | 1 |
| Bromberg, E | 1 |
3 other studies available for dehydroepiandrosterone and Cognitive Decline
| Article | Year |
|---|---|
Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy.
Topics: Breast Neoplasms; Cognitive Dysfunction; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Est | 2022 |
Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
Topics: Antineoplastic Agents; Breast Neoplasms; Cognitive Dysfunction; Cohort Studies; Dehydroepiandrostero | 2019 |
Age Effects on Cognitive and Physiological Parameters in Familial Caregivers of Alzheimer's Disease Patients.
Topics: Adult; Age Factors; Aged; Alzheimer Disease; Brain-Derived Neurotrophic Factor; Caregivers; Case-Con | 2016 |